Your browser doesn't support javascript.
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.
Chua, Brendon Y; Sekiya, Toshiki; Koutsakos, Marios; Nomura, Naoki; Rowntree, Louise C; Nguyen, Thi H O; McQuilten, Hayley A; Ohno, Marumi; Ohara, Yuki; Nishimura, Tomohiro; Endo, Masafumi; Itoh, Yasushi; Habel, Jennifer R; Selva, Kevin J; Wheatley, Adam K; Wines, Bruce D; Hogarth, P Mark; Kent, Stephen J; Chung, Amy W; Jackson, David C; Brown, Lorena E; Shingai, Masashi; Kedzierska, Katherine; Kida, Hiroshi.
  • Chua BY; Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE) Hokkaido University, Sapporo, Japan.
  • Sekiya T; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Koutsakos M; Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE) Hokkaido University, Sapporo, Japan.
  • Nomura N; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Rowntree LC; International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Nguyen THO; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • McQuilten HA; International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Ohno M; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Ohara Y; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Nishimura T; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Endo M; International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Itoh Y; KM Biologics Co. Ltd., Kumamoto, Japan.
  • Habel JR; KM Biologics Co. Ltd., Kumamoto, Japan.
  • Selva KJ; KM Biologics Co. Ltd., Kumamoto, Japan.
  • Wheatley AK; Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Otsu, Japan.
  • Wines BD; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Hogarth PM; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Kent SJ; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Chung AW; Immune Therapies Group, Burnet Institute, Melbourne, Australia.
  • Jackson DC; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia.
  • Brown LE; Department of Pathology, The University of Melbourne, Parkville, Australia.
  • Shingai M; Immune Therapies Group, Burnet Institute, Melbourne, Australia.
  • Kedzierska K; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia.
  • Kida H; Department of Pathology, The University of Melbourne, Parkville, Australia.
PLoS Pathog ; 18(10): e1010891, 2022 10.
Article in English | MEDLINE | ID: covidwho-2112643
ABSTRACT
Although antibody-inducing split virus vaccines (SV) are currently the most effective way to combat seasonal influenza, their efficacy can be modest, especially in immunologically-naïve individuals. We investigated immune responses towards inactivated whole influenza virus particle vaccine (WPV) formulations, predicated to be more immunogenic, in a non-human primate model, as an important step towards clinical testing in humans. Comprehensive analyses were used to capture 46 immune parameters to profile how WPV-induced responses differed to those elicited by antigenically-similar SV formulations. Naïve cynomolgus macaques vaccinated with either monovalent or quadrivalent WPV consistently induced stronger antibody responses and hemagglutination inhibition (HI) antibody titres against vaccine-matched viruses compared to SV formulations, while acute reactogenic effects were similar. Responses in WPV-primed animals were further increased by boosting with the same formulation, conversely to modest responses after priming and boosting with SV. 28-parameter multiplex bead array defined key antibody features and showed that while both WPV and SV induced elevated IgG responses against A/H1N1 nucleoprotein, only WPV increased IgG responses against A/H1N1 hemagglutinin (HA) and HA-Stem, and higher IgA responses to A/H1N1-HA after each vaccine dose. Antibodies to A/H1N1-HA and HA-Stem that could engage FcγR2a and FcγR3a were also present at higher levels after one dose of WPV compared to SV and remained elevated after the second dose. Furthermore, WPV-enhanced antibody responses were associated with higher frequencies of HA-specific B-cells and IFN-γ-producing CD4+ T-cell responses. Our data additionally demonstrate stronger boosting of HI titres by WPV following prior infection and support WPV administered as a priming dose irrespective of the follow up vaccine for the second dose. Our findings thus show that compared to SV vaccination, WPV-induced humoral responses are significantly increased in scope and magnitude, advocating WPV vaccination regimens for priming immunologically-naïve individuals and also in the event of a pandemic outbreak.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / Influenza A Virus, H1N1 Subtype Type of study: Cohort study / Prognostic study Topics: Vaccines Limits: Animals / Humans Language: English Journal: PLoS Pathog Year: 2022 Document Type: Article Affiliation country: Journal.ppat.1010891

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / Influenza A Virus, H1N1 Subtype Type of study: Cohort study / Prognostic study Topics: Vaccines Limits: Animals / Humans Language: English Journal: PLoS Pathog Year: 2022 Document Type: Article Affiliation country: Journal.ppat.1010891